...
【24h】

Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.

机译:归芪合剂对大鼠糖尿病肾病进展的保护作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Huang Qi (root of Astragalus membranaceus) and Dang Gui ( Angelica sinensis), two of the most widely used herbs in traditional Chinese medicine, have been proven to be effective in the treatment of diabetes mellitus (DM) although the underlying molecular mechanisms are not fully elucidated. This study was designed to investigate the protective effect of Dang Gui and Huang Qi mixture (GQM) on the development of diabetic nephropathy in rats with streptozotocin (STZ)-induced DM and the possible underlying molecular mechanism. The diabetic animal model was made by a single intraperitoneal injection of STZ and then treated with GQM or benazepril. Blood glucose, triglyceride (TG), cholesterol (CHO), high density lipoprotein (HDL), serum creatinine (Scr), creatinine clearance rate (Ccr), blood urea nitrogen (BUN), urine beta (2)-microglobin (beta (2)-MG), kidney/body weight (K/B) ratio, glomerular area (GA), renal transforming growth factor-beta (1) (TGF-beta (1)) mRNA expression and blood and renal angiotensin II (AngII) expression were determined 8 weeks after the treatment. The blood glucose, CHO and TG levels, BUN, SCr, Ccr. K/B ratio, GA, the excretion of beta (2)-MG, renal TGF-beta (1) mRNA expression and blood and renal AngII expression were significantly increased while the HDL level was decreased 8 week after STZ injection. The changes in blood glucose, TG, CHO and HDL were reversed by GQM, not by benazepril, whereas the changes in other variables were reversed by both GQM and benazepril. Our results suggest that GQM alleviates the disorder in blood glucose and lipids, protects against the progression of renal nephropathy in diabetic rats, probably by inhibiting the expression of AngII and TGF-beta (1) mRNA.
机译:黄芪(黄芪的根)和当归(当归)是传统中药中使用最广泛的两种草药,尽管其潜在的分子机制尚不明确,但已被证明可有效治疗糖尿病(DM)。充分阐明。本研究旨在探讨当归黄芪合剂对链脲佐菌素诱发的糖尿病大鼠糖尿病肾病的保护作用及其可能的分子机制。糖尿病动物模型是通过腹膜内注射STZ制成的,然后用GQM或贝那普利治疗。血糖,甘油三酸酯(TG),胆固醇(CHO),高密度脂蛋白(HDL),血清肌酐(Scr),肌酐清除率(Ccr),血尿素氮(BUN),尿液beta(2)-微球蛋白(beta( 2)-MG),肾脏/体重(K / B)比,肾小球面积(GA),肾脏转化生长因子-β(1)(TGF-β(1))mRNA表达以及血液和肾脏血管紧张素II(AngII)在治疗后8周确定)表达。血糖,CHO和TG水平,BUN,SCr,Ccr。 STZ注射后8周,K / B比,GA,β(2)-MG的排泄,肾TGF-β(1)mRNA表达以及血液和肾AngII表达显着增加,而HDL水平降低。 GQM可以逆转血糖,TG,CHO和HDL的变化,而不是贝那普利可以逆转,而GQM和贝那普利都可以逆转其他变量的变化。我们的研究结果表明,GQM可能通过抑制AngII和TGF-β(1)mRNA的表达来减轻糖尿病大鼠的血糖和脂质紊乱,预防肾脏肾病的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号